Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
2(8%)
Results Posted
0%(0 trials)
Terminated
3(12%)

Phase Distribution

Ph phase_2
1
4%
Ph not_applicable
2
8%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

25

all time

Status Distribution
Active(2)
Completed(6)
Terminated(4)
Other(13)

Detailed Status

unknown13
Completed6
Terminated3
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
2
Success Rate
66.7%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (33.3%)
N/A2 (66.7%)

Trials by Status

terminated312%
unknown1352%
withdrawn14%
completed624%
recruiting28%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT06967831

Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells

Recruiting
NCT06139042

Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

Recruiting
NCT05989555

Effects of Radioactive Iodine on the Immune System in Thyroid Cancer

Unknown
NCT04100122

Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient

Completed
NCT05667350

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)

Unknown
NCT02329808

Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

Completed
NCT04717219

Myeloid Cells in Aortic Valve Stenosis

Unknown
NCT03155113Not Applicable

Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy

Completed
NCT01414712

Circulating Tumor Cells in Prostate Cancer Patients

Terminated
NCT03870828

Clinical Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF) - a Multicenter Prospective Study

Unknown
NCT03089099

Expression of Molecular Markers in Circulating Tumor Cells of Metastatic Castration-Resistant Prostate Cancer

Unknown
NCT02723526

Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer

Unknown
NCT02682550

Danger Response in Polytrauma Patients

Unknown
NCT01377961Not Applicable

Effect of Lycopene and Isoflavones on Glucose Metabolism

Withdrawn
NCT01071837Phase 2

APG101 in Glioblastoma

Completed
NCT00281190

Comparison of Alveolar Macrophages in Individuals With COPD Versus Smokers With Normal Pulmonary Function

Completed
NCT02117518

Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients

Unknown
NCT00281203

Comparison of Alveolar Macrophages in Healthy Individuals Versus Individuals With COPD

Completed
NCT00709397

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy

Terminated
NCT00539318

Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

Terminated

Drug Details

Intervention Type
PROCEDURE
Total Trials
25